680
ASSOCIATION FOR ACADEMIC SURGERY AND SOCIETY OF UNIVERSITY SURGEONS—ABSTRACTS
61.6. The Usefulness of POSSUM Score for Elective Liver Surgery: Analysis of consecutive 100 Patients of Hepatocellular Carcinoma. K. Akahoshi,1 T. Ochiai,1 E. Katsuta,1 K. Nakao,1 H. Matsunaga,1 T. Furuyama,1 H. Itou,1 T. Miura,1 S. Matsumura,1 D. Ban,1 T. Irie,1 A. Kudou,1 N. Nakamura,1 S. Tanaka,1 M. Tanabe1; 1Tokyo Medical And Dental University - Department Of Hepato-Biliary-Pancreatic Surgery, Bunkyo-ku, TOKYO, Japan
61.7. Anal Squamous Cell Cancer in African Americans With and Without HIV: A Comparative Study. D. Wood,1 J. S. Turner,1 C. Lokko,1 E. W. Childs,1 C. E. Clark1; 1Morehouse School Of Medicine - Colon And Rectal Surgery/General Surgery/Morehouse, Atlanta, GA, USA
61.8. Treatment Strategy against Gastric Cancer with Peritoneal Metastasis in Its Early Developing Phase. D. Kobayashi,1 N. Iwata,1 M. Kanda,1 C. Tanaka,1 S. Yamada,1 G. Nakayama,1 T. Fujii,1 H. Sugimoto,1 M. Koike,1 S. Nomoto,1 M. Fujiwara,1 Y. Kodera1; 1Nagoya University Graduate School Of Medicine, Gastroenterological Surgery, Nagoya, Aichi, Japan
61.9. Oncolytic Gene Therapy Using Recombinant Vaccinia Virus GLV-1h68 Efficiently Kills Sorafenib-Resistant Hepatocellular Carcinoma. J. W. Ady,1 J. Heffner,1 K. Mojica,1 D. Love,2 L. J. Belin,1 E. Klein,1 T. Yu,3 N. Chen,3 J. Aguilar,3 A. A. Szalay,3,4 Y. Fong1; 1Memorial Sloan-Kettering Cancer Center - Surgery, New York, NY, USA; 2Weill Cornell Medical College - Cell And Developmental Biology, New York, NY, USA; 3Genelux Corporation, San Diego, CA, USA; 4University Of Wrzburg - Rudolph Virchow Center For Experimental Biomedicine And Institute For Molecular Infection Biology, Wrzburg, BAVARIA, Germany
61.10. Peritoneal Surface Disease with Synchronous Hepatic Involvement Treated with Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC). R. W. Randle,1 C. J. Clark,1 K. R. Swett,2 P. Shen,1 J. H. Stewart,1 E. A. Levine,1 K. I. Votanopoulos1; 1 Wake Forest University School Of Medicine - General Surgery, Winston-Salem, NC, USA; 2Wake Forest University School Of Medicine - Biostatistics, Winston-Salem, NC, USA
J. Y. Kim,6 B. Sepesi,1 J. A. Ajani,3 R. Komaki,4 J. Erasmus,2 D. M. Maru,1 R. J. Mehran,1 D. C. Rice,1 J. A. Roth,1 A. A. Vaporciyan,1 G. L. Walsh,1 W. L. Hofstetter,1 S. G. Swisher1; 1 University Of Texas MD Anderson Cancer Center Cardiovascular & Thoracic Surgery, Houston, Texas, USA; 2 University Of Texas MD Anderson Cancer Center Diagnostic Radiology, Houston, Texas, USA; 3University Of Texas MD Anderson Cancer Center - GI Medical Oncology, Houston, Texas, USA; 4University Of Texas MD Anderson Cancer Center - Radiation Oncology, Houston, Texas, USA; 5University Of Texas MD Anderson Cancer Center - Pathology, Houston, Texas, USA; 6City Of Hope National Medical Center - Thoracic Surgery, Duarte, CA, USA
61.13. Dyslipidemia as a Possible Risk Factor for Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease without Cirrhosis. P. R. Varley,1 A. Sourianarayanane,2 J. Behari,2 A. Tsung1; 1University Of Pittsburgh - Department Of Surgery, Pittsburgh, PA, USA; 2University Of Pittsburgh - Division Of Gastroenterology, Hepatology, And Nutrition, Pittsburgh, PA, USA
61.14. Slug Modulates Colon Cancer 5-Fluorouracil Sensitivity Through miR-145 Repression. D. Quirk,1 V. J. Findaly,1 C. Wang,1 K. Hurst,1 S. G. Vaena,1 D. K. Watson,1 E. R. Camp1; 1Medical University Of South Carolina, Charleston, SC, USA
61.15. Minimally Invasive Resection Of Hepatic Metastases From Colorectal Cancer Reduces Time To Initiation Of Adjuvant Chemotherapy. K. Han,1 B. J. Golas,1 Z. M. Dong,1 A. P. Chidi,1 J. L. Steel,1 D. A. Geller,1 A. Tsung1; 1 University Of Pittsburgh - Department Of Surgery, Pittsburgh, PA, USA
61.16. Utilizing RNA aptamers for Biomarker Discovery in a Novel Cell Culture System for Hepatocellular Carcinoma. I. A. Naqvi,1 P. Ray,1 S. S. Choi,1 A. Diehl,1 R. R. White1; 1Duke University - School Of Medicine, Durham, NC, USA
61.11. Effect of Postoperative Morbidity on Long-term Survival After Gastrectomy for Gastric Cancer. L. X. Jin,1 L. E. Moses,1 Y. Yan,2 W. G. Hawkins,1 D. C. Linehan,1 S. M. Strasberg,1 R. C. Fields1; 1Washington University Division Of Hepatobiliary, Pancreatic, Gastrointestinal, And Oncologic Surgery/Department Of Surgery, St. Louis, MO, USA; 2Washington University - Division Of Public Health Sciences, St. Louis, MO, USA
61.17. Correlation Between Quality of Life Measures in Medically Underserved Hepatocellular Carcinoma Patients. R. J. Escamilla,1 L. S. Kao,1 R. L. Wiatrek,1 T. C. Ko,1 C. J. Wray1; 1University Of Texas Health Science Center At Houston - Department Of Surgery, Houston, TX, USA
61.12. Esophageal Tumor Thickness on Computed Tomography as a Predictor of Residual Tumor in Esophageal Adenocarcinoma Following Preoperative Chemoradiation. A. M. Francis,1 A. M. Correa,1 S. L. Betancourt-Cuellar,2
61.18. Reoperation after HIPEC: Long-Term Analysis. A. M. Blakely,1 W. G. Cioffi,1 T. J. Miner1; 1Brown University School Of Medicine - Department Of Surgery, Providence, RI, USA